# ARA-290 (cibinetide) for sarcoidosis nerve loss and pain

Source: https://pepvault.app/research/ara-290-culver-2017

Last updated: 2026-11-17

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [ARA-290](https://pepvault.app/research#ara-290)

Randomized trial · people

# ARA-290: more corneal nerve fibers at 28 days in sarcoidosis, 4 mg arm

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In this short human trial, ARA-290 increased small nerve fibers in the eye and skin at the 4 mg dose. The evidence that it eases pain more than placebo is less clear.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 64
- **Published:** 2017
- **Journal:** Invest Ophthalmol Vis Sci

## What they tested

Does daily cibinetide (ARA-290) regrow small nerve fibers and ease nerve pain in people with sarcoidosis who have lost small nerve fibers?

## How the study was done

A phase 2b, randomized, placebo-controlled trial in 64 people with sarcoidosis-linked small nerve fiber loss and nerve pain. They got 1, 4 or 8 mg of cibinetide a day or placebo (a dummy treatment) for 28 days. The main measure was the change in corneal nerve fiber area, which counts nerve fibers in the eye's clear front layer using a special microscope.

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

Compared with placebo, corneal nerve fiber area rose by 697 μm2 in the 4 mg arm (P = 0.012). The 109 μm2 rise in the 1 mg arm and the 431 μm2 rise in the 8 mg arm were not statistically clear. The 4 mg arm also gained regrowing nerve fibers in the skin (GAP-43+ fibers, P = 0.035), and changes in corneal nerve area tracked with changes in skin nerve fibers (ρ = 0.575) and in the 6-minute walk test (ρ = 0.645). Pain improved significantly in all groups. Among people with moderate to severe pain, the 4 mg arm had a placebo-corrected drop described as clinically meaningful (P = 0.157).

## What it doesn’t show

It was a small, 28-day trial split across four arms, and only the 4 mg dose clearly beat placebo on the main measure. Nerve fiber counts are stand-in measures for the disease, and the pain result for people with moderate to severe pain came from a subgroup, with P = 0.157.

## The paper

Culver et al. Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain. Invest Ophthalmol Vis Sci. 2017.

- [PubMed (PMID 28475703)](https://pubmed.ncbi.nlm.nih.gov/28475703/)
- [The paper (DOI 10.1167/iovs.16-21291)](https://doi.org/10.1167/iovs.16-21291)

## The compound

- [ARA-290: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

## More studies on ARA-290

- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013) Randomized trial · people · 2013
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012) Randomized trial · people · 2012
- [ARA-290 eased nerve-injury pain for up to 20 weeks in rats](https://pepvault.app/research/ara-290-swartjes-2014) Animal study · rats · 2014
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### ARA-290

- [ARA-290: the full reference](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/ara-290-10mg)

### Studies

- [ARA-290 eased neuropathic symptoms in sarcoidosis nerve fiber loss](https://pepvault.app/research/ara-290-dahan-2013)
- [ARA-290 improved small fiber neuropathy symptoms in sarcoidosis](https://pepvault.app/research/ara-290-heij-2012)
- [All 4 studies](https://pepvault.app/research#ara-290)

### Compared with

- [BPC-157 vs ARA-290](https://pepvault.app/peptides/compare/bpc-157-vs-ara-290)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Taking ARA-290? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on ARA-290](https://pepvault.app/research#ara-290)

## The library

- [ARA-290](https://pepvault.app/peptides/ara-290)
- [ARA-290 dose guide](https://pepvault.app/lab/dosage/ara-290)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
